National and local events relevant to the Target: BP community. Access our library of on-demand webinars.
- This event has passed.
Partnering with Patients using self-measured blood pressure and collaborative communication – Step 3 in hypertension control
07/15/21 @ 12:00 pm – 1:00 pm CDT
When partnering with patients, the goal is to empower patients to control their BP. This can be accomplished through a combination of using evidence-based communication strategies, helping patients accurately self-measure, and by directing patients and families to resources that support medication adherence and healthy lifestyles.
Hear from nationally renowned experts:
• Karen L. Margolis, MD, MPH, Executive Director of Research, HealthPartners Institute
• Monika M. Safford, MD, Chief of General Internal Medicine, Weill Cornell Medical College
• Yvonne Commodore-Mensah, PhD, MHS, RN, Cardiovascular Nurse Epidemiologist, Johns Hopkins Medicine
Register in advance for this webinar. After registering, you will receive a confirmation email containing information about joining the webinar.
Learning objectives
• Describe evidence-based use of self-measured blood pressure (SMBP)and best practices for engaging patients in self-management of their blood pressure
• Recognize importance and how to employ evidence-based collaborative communication strategies with patients with hypertension
• Access available supporting tools and resources to support use of SMBP and collaborative communication strategies
Preliminary Agenda:
| 12:00 to 12:15pm CST | Karen Margolis, MD | Rationale and evidence-based practice of SMBP | Corresponds to Learning Objective 1 |
| 12:15 to 12:40pm CST | Yvonne Commodore-Mensah, MD, MHS, RN Monika Safford, MD | Employing effective engagement of patients in SMBP with collaborative communication | Corresponds to Learning Objective 2 |
| 12:40 to 12:45pm CST | Neha Sachdev, MD | Review available tools and resources | Corresponds to Learning Objective 3 |
| 12:45 to 1:00pm CST | All | Question and answer session | Corresponds to Learning Objective 1, 2, 3 |
Joint Accreditation Statements
In support of improving patient care, this activity has been planned and implemented by the American Heart Association. The American Heart Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA Credit Designation Statement – Physicians
The American Heart Association designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA Credit Acceptance Statement – Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.00 hours of Category I credit for completing this program.
AANP Credit Acceptance Statement – Nurse Practitioners
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.
**AMA Credit must be claimed within 6 months of attendance. Credit will no longer be available to claim after January 15, 2022.
ANCC Credit Designation Statement – Nurses
The maximum number of hours awarded for this CE activity is 1.00 contact hours.
**ANCC Credit must be claimed within 6 months of attendance. CE credit will no longer be available to claim after January 15, 2022.
Disclosure Policy
All persons who develop and/or control educational content in CE activities provided by the American Heart Association will disclose to the audience all financial relationships with any commercial supporters of this activity as well as with other commercial interests whose lines of business are related to the CE-certified content of this activity. In addition, presenters will disclose unlabeled/unapproved uses of drugs or devices discussed in their presentations. Such disclosures will be made in writing in course presentation materials.